Global and United States Human Vaccination Market Report & Forecast 2022-2028

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Market Analysis and Insights: Global and United States Human Vaccination Market

This report focuses on global and United States Human Vaccination market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Human Vaccination market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Inactivated Vaccine accounting for % of the Human Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Government Institution was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Human Vaccination market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Human Vaccination Scope and Market Size

Human Vaccination market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Human Vaccination market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Human Vaccination market is segmented into

Inactivated Vaccine

Live-attenuated Vaccine

mRNA Vaccine

Conjugate Vaccine

Other

Segment by Application, the Human Vaccination market is segmented into

Government Institution

Private Sector

Other

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Human Vaccination Market Share Analysis

Human Vaccination market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Vaccination business, the date to enter into the Human Vaccination market, Human Vaccination product introduction, recent developments, etc.

The major vendors covered:

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

KM Biologics

IMBCAMS

Convac

NCPC

Bio Kangtai

Dynavax

Hissen

KM Biologics

LG Life Sciences

Serum Institute

Pfizer